REASONS FOR DISCONTINUATION OF TNF INHIBITORS IN PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS ACCORDING TO DRUG HISTORY

被引：0
|
作者：
Matianova, E. [1 ]
Gordeev, A. [1 ]
Galushko, E. [1 ]
机构：
[1] VA Nasonova Rheumatol Res Inst, Rheumatoid Arthritis Evolut Lab, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2354
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0346
引用
收藏
页码：1298 / 1299
页数：2
相关论文
共 50 条
  • [41] THERAPEUTIC STRATEGIES IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS OF A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2020 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
    Roodenrijs, N. M. T.
    Hamar, A.
    Kedves, M.
    Nagy, G.
    Van Laar, J. M.
    Van der Heijde, D.
    Welsing, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 953 - 954
  • [42] DRUG RETENTION AND REASONS FOR DISCONTINUATION OF BIOLOGICS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS - THE ANSWER COHORT STUDY
    Ebina, K.
    Etani, Y.
    Maeda, Y.
    Okita, Y.
    Hirao, M.
    Yamamoto, W.
    Hashimoto, M.
    Murata, K.
    Hara, R.
    Nagai, K.
    Hiramatsu, Y.
    Son, Y.
    Amuro, H.
    Fujii, T.
    Okano, T.
    Ueda, Y.
    Katayama, M.
    Okano, T.
    Kumanogoh, A.
    Okada, S.
    Nakata, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 234 - 235
  • [43] Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis
    Takanashi, Satoshi
    Takeuchi, Tsutomu
    Kaneko, Yuko
    RHEUMATOLOGY, 2024,
  • [44] Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital
    Hecquet, Sophie
    Combier, Alice
    Steelandt, Alexia
    Pons, Marion
    Wendling, Daniel
    Molto, Anna
    Miceli-Richard, Corinne
    Allanore, Yannick
    Avouac, Jerome
    RHEUMATOLOGY, 2023, 62 (12) : 3866 - 3874
  • [45] Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
    Roodenrijs, Nadia M. T.
    Hamar, Attila
    Kedves, Melinda
    Nagy, Gyorgy
    van Laar, Jacob M.
    van der Heijde, Desiree
    Welsing, Paco M. J.
    RMD OPEN, 2021, 7 (01):
  • [46] DIAGNOSTIC ISSUES IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS OF A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2020 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF DIFFICULT-TO-TREAT RHEUMATOID
    Roodenrijs, N. M. T.
    Kedves, M.
    Hamar, A.
    Nagy, G.
    Van Laar, J. M.
    Van der Heijde, D.
    Welsing, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 265 - 266
  • [47] Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis
    Yoshii, Ichiro
    Sawada, Naoya
    Chijiwa, Tatsumi
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (11) : 1947 - 1954
  • [48] Inappropriate treatment response to DMARDs: A pathway to difficult-to-treat rheumatoid arthritis
    Guo, Hongtao
    Li, Li
    Liu, Bin
    Lu, Peipei
    Cao, Zhiwen
    Ji, Xinyu
    Ouyang, Guilin
    Nie, Zhixin
    Lyu, Aiping
    Lu, Cheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [49] A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management
    Carly Conran
    Jason Kolfenbach
    Kristine Kuhn
    Christopher Striebich
    Larry Moreland
    Current Rheumatology Reports, 2023, 25 : 285 - 294
  • [50] Comment on: Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis
    Nagashima, Takao
    Yabe, Hiroki
    Kobashigawa, Tsuyoshi
    RHEUMATOLOGY, 2024,
12345